Common Contracts
65 similar Employment Agreement contracts by Cumberland Pharmaceuticals Inc
March 9, 2023 John Hamm Brentwood, TN 37216Employment Agreement • March 15th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Financial Officer the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023 Chris Bitterman Alpharetta, GA 37090Employment Agreement • March 15th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Vice President of Sales and Marketing the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023 Todd Anthony Franklin, TN 37064Employment Agreement • March 15th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Vice President of Organizational Development the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023Employment Agreement • March 15th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023 James “Jim” Herman Nashville, TN 37221Employment Agreement • March 15th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Jim Herman Executive Vice President National Accounts & Chief Compliance Officer as by Cumberland Pharmaceuticals Inc.
March 7, 2022Employment Agreement • March 13th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of John Hamm as Senior Director of Finance & Accounting & Chief Financial Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Employment Agreement • March 13th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of James Herman as Executive Vice President, National Accounts and Chief Compliance Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Employment Agreement • March 13th, 2023 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Effective January 1, 2022, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 7, 2022Employment Agreement • May 13th, 2022 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of John Hamm as Senior Director of Finance & Accounting & Chief Financial Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Employment Agreement • May 13th, 2022 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of James Herman as Executive Vice President, National Accounts and Chief Compliance Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Employment Agreement • May 13th, 2022 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Effective January 1, 2022, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 7, 2022Employment Agreement • May 13th, 2022 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Chief Development & Operations Officer by Cumberland Pharmaceuticals Inc.
May 14, 2021Employment Agreement • May 14th, 2021 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of John Hamm as Senior Director Finance & Accounting and Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Employment Agreement • March 12th, 2021 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Employment Agreement • March 12th, 2021 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Effective January 1, 2021, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 8, 2021Employment Agreement • March 12th, 2021 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Employment Agreement • March 12th, 2021 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Employment Agreement • March 12th, 2021 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Employment Agreement • March 20th, 2020 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Employment Agreement • March 20th, 2020 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Employment Agreement • March 20th, 2020 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Employment Agreement • March 20th, 2020 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Effective January 1, 2020, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 16, 2020Employment Agreement • March 20th, 2020 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Employment Agreement • March 12th, 2019 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Employment Agreement • March 12th, 2019 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Employment Agreement • March 12th, 2019 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Employment Agreement • March 12th, 2019 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Effective January 1, 2019, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 8, 2019Employment Agreement • March 12th, 2019 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Employment Agreement • March 9th, 2018 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Employment Agreement • March 9th, 2018 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Employment Agreement • March 9th, 2018 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Employment Agreement • March 9th, 2018 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Effective January 1, 2018, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2018Employment Agreement • March 9th, 2018 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2017Employment Agreement • March 13th, 2017 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2017Employment Agreement • March 13th, 2017 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
